Chemed Shareholders Seeking to Recover Losses through Investor Lawsuit Encouraged to Contact Securities Lawyers at Deans & Lyons LLP

DALLAS, May 30, 2013 /PRNewswire/ -- Securities lawyers are investigating Chemed (NYSE: CHE) due to potential violations of shareholder protection laws. Concerned CHE stockholders who seek to recover value for their shares should contact securities lawyer Hamilton Lindley at 877-819-8033 or [email protected] about potential investor claims.

Securities lawyers are investigating the company due to a False Claims Act complaint filed by the U.S. Government.  The allegations in that lawsuit involve billing Medicare for unnecessary crisis care services and admitting patients who were not eligible for the Medicare hospice benefit.  On news of this lawsuit, Chemed stock price dropped precipitously.

Deans & Lyons LLP has significant experience representing investors in securities class action and derivative lawsuits nationwide.  Stockholders with concerns about their CHE stock or anyone with information about this situation should contact Hamilton Lindley at [email protected] or 877-819-8033.

Hamilton Lindley
Deans & Lyons LLP
325 N. Saint Paul Street, Suite 1500
Dallas, TX 75201
(877) 819-8033 Toll Free
(214) 965-8500 Telephone
(214) 965-8505 Facsimile
[email protected]
deanslyons.com

SOURCE Deans & Lyons LLP

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED